Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.20 +0.00 (+2.07%)
As of: Oct 21, 2026 · 1:04 PM EDT

Vistagen Therapeutics (VTGN) Receivables - Other (2019 - 2023)

Updated

Vistagen Therapeutics (VTGN) recorded Receivables - Other of $380,000 in fiscal Q1 2024 (quarter ended Jun 30, 2023).

Analysis

Vistagen Therapeutics (VTGN) Receivables - Other (2019 - 2023) Analysis & Trends

At the end of FY2021 (ended Mar 31, 2021), Vistagen Therapeutics reported Receivables - Other of $40,600.

  • Across earlier fiscal years, Receivables - Other came in at $300,000 in FY2019.
  • The fiscal Q1 2024 figure is the lowest quarterly Receivables - Other since fiscal Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 Vistagen Therapeutics 8.58 Mn -207.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 380,000.00
Jun 30, 2021 44,000.00
Mar 31, 2021 40,600.00
Mar 31, 2019 300,000.00
API Access

Vistagen Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VTGN&period=max&api_key=YOUR_API_KEY